Vanda Pharmaceuticals
VNDA
VNDA
188 hedge funds and large institutions have $371M invested in Vanda Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 76 increasing their positions, 61 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
+11
Holders Change %
+6.21%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
22
Increased
76
Reduced
61
Closed
11
Calls
$638K
Puts
$30K
Net Calls
+$608K
Net Calls Change
+$624K
Top Buyers
| 1 |
1
BlackRock
New York
|
$71.2M |
| 2 |
2
Goldman Sachs
New York
|
$13.9M |
| 3 |
PAMS
3
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
$10.3M |
| 4 |
4
Bank of Montreal
Toronto,
Ontario, Canada
|
$1.99M |
| 5 |
5
Man Group
London,
United Kingdom
|
$1.8M |
